Financhill
Back

Acasti Pharma Quote, Financials, Valuation and Earnings

Acasti Pharma Price Quote

$2.77
-0.12 (-4.15%)
(Updated: May 9, 2024 at 5:20 PM ET)

Acasti Pharma Key Stats

Buy
55
Acasti Pharma (ACST) is a Buy

Day range:
$2.76 - $2.91
52-week range:
$1.72 - $3.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.42%

Volume:
21.2K
Avg. volume:
24.1K
1-year change:
4.71%
Market cap:
$27.2M
Revenue:
$0
EPS:
$-4.58

How Much Does Acasti Pharma Make?

Data Unavailable

Is Acasti Pharma Growing As A Company?

Data Unavailable

Acasti Pharma Stock Price Performance

  • Did Acasti Pharma Stock Go Up Last Month?
    Acasti Pharma share price went down by -15% last month
  • Did ACST's Share Price Rise Over The Last Year?
    ACST share price rose by 4.71% over the past 1 year

What Is Acasti Pharma 52-Week High & Low?

Acasti Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Acasti Pharma?

  • How Much Debt Does Acasti Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Acasti Pharma Have?
    Cash and short term investments quarterly total is $25.1M
  • What Is Acasti Pharma’s Book Value Per Share?
    Book value per share is 6.88

Is Acasti Pharma Cash Flow Positive?

  • What Is ACST Cash Flow From Operations?
    Cash flow from operations (TTM) is -$13.6M
  • What Is Acasti Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.4M
  • What Is Acasti Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5M

Acasti Pharma Return On Invested Capital

Data Unavailable

Acasti Pharma Earnings Date & Stock Price

Acasti Pharma Competitors

  • Who Are Acasti Pharma's Competitors?
    Below is a list of companies who compete with Acasti Pharma or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • ESSA Pharma Inc (EPIX)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

Acasti Pharma Dividend Yield

Data Unavailable

Acasti Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 8.85%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 5.85
Upside from Last Price: 102.57%

Major Shareholders

  • How many ACST shares are owned by institutional investors?
    1.6M ACST shares are owned by institutional investors
  • How many ACST shares are owned by insiders?
    780.7K ACST shares are owned by insiders